Although OMICS Group focused in the year 2011-2014 on exploring the novel research in the field of Pharmaceutics and NDDS, it spared the year 2015 to share international experiences with the world leaders from Pharmaceutical and Bio Pharmaceutical Research diverting a major section of research to focus on formulating a variety of poorly soluble and highly unstable substances, reporting it to be the significant arena in pharmaceutical research